Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1994 Sep;38(9):2227–2229. doi: 10.1128/aac.38.9.2227

Evaluation of effects of altered gastric pH on absorption of dapsone in healthy volunteers.

G A Breen 1, J M Brocavich 1, J V Etzel 1, V Shah 1, P Schaefer 1, S Forlenza 1
PMCID: PMC284721  PMID: 7811056

Abstract

A prospective, randomized, crossover study was performed with seven healthy volunteers to address the effect of increased gastric pH on dapsone absorption. Subjects were randomized to receive a single 100-mg dose of dapsone or a single 100-mg dose of dapsone in addition to 30 ml of a high potency antacid 1 h before dapsone administration and hourly thereafter for a total of 10 doses. Dapsone concentrations in serum were measured periodically for 48 h. No statistical differences between the two regimens were noted when mean dapsone maximal initial concentrations, times to peak, and areas under the curve were compared. These data suggest that an increase in gastric pH has little or no effect on the absorption of dapsone in healthy subjects.

Full text

PDF
2227

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahmad R. A., Rogers H. J. Pharmacokinetics and protein binding interactions of dapsone and pyrimethamine. Br J Clin Pharmacol. 1980 Nov;10(5):519–524. doi: 10.1111/j.1365-2125.1980.tb01798.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Ahmad R. A., Rogers H. J. Plasma and salivary pharmacokinetics of dapsone estimated by a thin layer chromatographic method. Eur J Clin Pharmacol. 1980 Feb;17(2):129–133. doi: 10.1007/BF00562621. [DOI] [PubMed] [Google Scholar]
  3. Carr K., Oates J. A., Nies A. S., Woosley R. L. Simultaneous analysis of dapsone and monoacetyldapsone employing high performance liquid chromatography: a rapid method for determination of acetylator phenotype. Br J Clin Pharmacol. 1978 Nov;6(5):421–427. doi: 10.1111/j.1365-2125.1978.tb04606.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cockcroft D. W., Gault M. H. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31–41. doi: 10.1159/000180580. [DOI] [PubMed] [Google Scholar]
  5. Glazko A. J., Dill W. A., Montalbo R. G., Holmes E. L. A new analytical procedure for dapsone. Application to blood-level and urinary-excretion studies in normal men. Am J Trop Med Hyg. 1968 May;17(3):465–473. [PubMed] [Google Scholar]
  6. Horowitz H. W., Jorde U. P., Wormser G. P. Drug interactions in use of dapsone for Pneumocystis carinii prophylaxis. Lancet. 1992 Mar 21;339(8795):747–747. doi: 10.1016/0140-6736(92)90649-n. [DOI] [PubMed] [Google Scholar]
  7. Huengsberg M., Castelino S., Sherrard J., O'Farrell N., Bingham J. Does drug interaction cause failure of PCP prophylaxis with dapsone? Lancet. 1993 Jan 2;341(8836):48–48. doi: 10.1016/0140-6736(93)92519-y. [DOI] [PubMed] [Google Scholar]
  8. Lake-Bakaar G., Quadros E., Beidas S., Elsakr M., Tom W., Wilson D. E., Dincsoy H. P., Cohen P., Straus E. W. Gastric secretory failure in patients with the acquired immunodeficiency syndrome (AIDS). Ann Intern Med. 1988 Sep 15;109(6):502–504. doi: 10.7326/0003-4819-109-6-502. [DOI] [PubMed] [Google Scholar]
  9. Lake-Bakaar G., Tom W., Lake-Bakaar D., Gupta N., Beidas S., Elsakr M., Straus E. Gastropathy and ketoconazole malabsorption in the acquired immunodeficiency syndrome (AIDS). Ann Intern Med. 1988 Sep 15;109(6):471–473. doi: 10.7326/0003-4819-109-6-471. [DOI] [PubMed] [Google Scholar]
  10. Metroka C. E., McMechan M. F., Andrada R., Laubenstein L. J., Jacobus D. P. Failure of prophylaxis with dapsone in patients taking dideoxyinosine. N Engl J Med. 1991 Sep 5;325(10):737–737. doi: 10.1056/nejm199109053251014. [DOI] [PubMed] [Google Scholar]
  11. Mills J., Leoung G., Medina I., Hopewell P. C., Hughes W. T., Wofsy C. Dapsone treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. Antimicrob Agents Chemother. 1988 Jul;32(7):1057–1060. doi: 10.1128/aac.32.7.1057. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Neuvonen P. J., Elonen E., Haapanen E. J. Acute dapsone intoxication: clinical findings and effect of oral charcoal and haemodialysis on dapsone elimination. Acta Med Scand. 1983;214(3):215–220. doi: 10.1111/j.0954-6820.1983.tb08597.x. [DOI] [PubMed] [Google Scholar]
  13. Neuvonen P. J., Elonen E., Mattila M. J. Oral activated charcoal and dapsone elimination. Clin Pharmacol Ther. 1980 Jun;27(6):823–827. doi: 10.1038/clpt.1980.117. [DOI] [PubMed] [Google Scholar]
  14. Pieters F. A., Zuidema J. The pharmacokinetics of dapsone after oral administration to healthy volunteers. Br J Clin Pharmacol. 1986 Oct;22(4):491–494. doi: 10.1111/j.1365-2125.1986.tb02924.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES